Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ AKTIE IM FOKUS: Safran gefragt - JPMorgan lobt Ausblick (DPA-AFX) +++ SAFRAN Aktie +4,14%

COCHLEAR Aktie

 >COCHLEAR Aktienkurs 
120.08 EUR    -17.6%    (TradegateBSX)
Ask: 120.4 EUR / 59 Stück
Bid: 119.18 EUR / 60 Stück
Tagesumsatz: 111 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
COCHLEAR Aktie über LYNX handeln
>COCHLEAR Performance
1 Woche: -3,9%
1 Monat: -4,9%
3 Monate: -10,2%
6 Monate: -16,9%
1 Jahr: -21,0%
laufendes Jahr: -1,8%
>COCHLEAR Aktie
Name:  COCHLEAR LTD
Land:  Australien
Sektor:  Gesundheit
ISIN/ Wkn:  AU000000COH5 / 898321
Symbol/ Ticker:  OC5 (Frankfurt)
Kürzel:  FRA:OC5, ETR:OC5, OC5:GR
Index:  -
Webseite:  https://www.cochlear.com/
Profil:  Cochlear Limited is a leading global provider of i..
>Volltext..
Marktkapitalisierung:  9861.86 Mio. EUR
Unternehmenswert:  9839.5 Mio. EUR
Umsatz:  1301.85 Mio. EUR
EBITDA:  331.35 Mio. EUR
Nettogewinn:  214.91 Mio. EUR
Gewinn je Aktie:  3.29 EUR
Schulden:  130.25 Mio. EUR
Liquide Mittel:  152.36 Mio. EUR
Operativer Cashflow:  131.3 Mio. EUR
Bargeldquote:  0.46
Umsatzwachstum:  -6.43%
Gewinnwachstum:  -2.23%
Dividende je Aktie:  2.4 EUR
Dividendenrendite:  1.7%
Dividendenschätzung:  2.3%
Div. Historie:  18.09.25 - 1.1986251€
20.03.25 - 1.1986251€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  COCHLEAR
Letzte Datenerhebung:  13.02.26
>COCHLEAR Kennzahlen
Aktien/ Unternehmen:
Aktien: 65.3 Mio. St.
Frei handelbar: 93.51%
Leerverk. Aktien: -
Rückkaufquote: 0.29%
Mitarbeiter: 5500
Umsatz/Mitarb.: 0.24 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 21%
Bewertung:
KGV: 45.68
KGV lG: 36.95
KUV: 7.26
KBV: 9.07
PEG-Ratio: 4.79
EV/EBITDA: 29.7
Rentabilität:
Bruttomarge: 73.89%
Gewinnmarge: 16.51%
Operative Marge: 21.61%
Managementeffizenz:
Gesamtkaprendite: 13.96%
Eigenkaprendite: 20.52%
>COCHLEAR Peer Group
Gesundheit
 
13.02.26 - 05:00
Why Austal, Cochlear, Nick Scali, and WiseTech shares are tumbling today (Fool)
 
These shares are ending the week in the red. But why? The post Why Austal, Cochlear, Nick Scali, and WiseTech shares are tumbling today appeared first on The Motley Fool Australia....
13.02.26 - 04:12
Everything you need to know about the latest Cochlear dividend (Fool)
 
Investors have reacted savagely to Cochlear today. The post Everything you need to know about the latest Cochlear dividend appeared first on The Motley Fool Australia....
13.02.26 - 02:24
Cochlear shares sink 17% on results day (Fool)
 
What's going on with this blue chip today? The post Cochlear shares sink 17% on results day appeared first on The Motley Fool Australia....
13.02.26 - 01:51
Cochlear shares slide on HY earnings drop, muted guidance (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
13.02.26 - 01:30
Cochlear-Aktie bricht nach gemischten Halbjahreszahlen ein/n (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
12.02.26 - 22:36
Cochlear posts modest sales growth but lower profit as Nexa launch continues (Fool)
 
Cochlear's HY26 saw profit decline and steady dividends, as Nexa implant rollout supports second-half growth plans. The post Cochlear posts modest sales growth but lower profit as Nexa launch continues appeared first on The Motley Fool Australia....
04.02.26 - 22:12
What can investors expect from ResMed, Cochlear and CSL shares this reporting season? (Fool)
 
Here's updated analysis on three of Australia's largest healthcare stocks. The post What can investors expect from ResMed, Cochlear and CSL shares this reporting season? appeared first on The Motley Fool Australia....
03.02.26 - 13:09
OrthoPediatrics Announces Expanded Enabling Technology Market Opportunity (GlobeNewswire EN)
 
OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older OrthoPediatrics partner iotaMotion receives FDA clearance for use of its iotaSOFT® cochlear implant insertion system in patients four years and older...
19.01.26 - 12:36
Health Care Roundup: Market Talk (WSJ EN)
 
Find insight on Bayer, Cochlear, Australian healthcare stocks and more in the latest Market Talks covering Health Care....
14.01.26 - 14:09
iotaMotion Receives FDA Clearance for Expanded Pediatric Use of iotaSOFT® Robotic-Assisted Cochlear Implant Insertion System (PR Newswire)
 
ST. PAUL, Minn., Jan. 14, 2026 /PRNewswire/ -- iotaMotion, Inc., creator of iotaSOFT®, the first and only FDA cleared robotic-assisted cochlear implant insertion system, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded pediatric use of its iotaSOFT®......
11.01.26 - 21:48
Cochlear shares lag the ASX 200 after a tough year. Is it time to buy? (Fool)
 
Investors continue to question valuation and wait for stronger earnings momentum. The post Cochlear shares lag the ASX 200 after a tough year. Is it time to buy? appeared first on The Motley Fool Australia....
08.01.26 - 14:18
Cochlear Announces Availability of Nucleus Nexa System to US Military Veterans (PR Newswire)
 
LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to eligible US military veterans at VA clinics nationwide. This milestone ensures that veterans......
18.12.25 - 14:12
Envoy Medical, Inc.: Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant (Newsfile)
 
White Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing......
16.12.25 - 14:12
Envoy Medical, Inc.: Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio (Newsfile)
 
White Bear Lake, Minnesota--(Newsfile Corp. - December 16, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing......
10.12.25 - 14:12
Envoy Medical, Inc.: Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant (Newsfile)
 
White Bear Lake, Minnesota--(Newsfile Corp. - December 10, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing......
04.12.25 - 14:06
Envoy Medical, Inc.: Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient (Newsfile)
 
White Bear Lake, Minnesota--(Newsfile Corp. - December 4, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing ......
02.12.25 - 03:24
Cochlear-aligned biotech off to a lacklustre start on the ASX (Fool)
 
Shares in this biotechnology company have slipped on debut on the ASX despite good news out of the US. The post Cochlear-aligned biotech off to a lacklustre start on the ASX appeared first on The Motley Fool Australia....
20.11.25 - 14:06
Envoy Medical, Inc.: Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery (Newsfile)
 
White Bear Lake, Minnesota--(Newsfile Corp. - November 20, 2025) - Envoy Medical Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing......
18.11.25 - 14:06
Envoy Medical, Inc.: Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial (Newsfile)
 
White Bear Lake, Minnesota--(Newsfile Corp. - November 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearin......
13.11.25 - 15:24
Smart Sound Ltd. Announces Patent Publication for Groundbreaking Hidden Cochlear Implant System (PR Newswire)
 
NIRIT, Israel, Nov. 13, 2025 /PRNewswire/ -- Smart Sound Ltd., a cochlear implant innovator, announces publication of a U.S. Patent for a "Hidden Cochlear Implant System with an In-Canal Wireless Transmission," a novel cochlear implant design fundamentally change the industry by providing......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Weiber lächeln, wenn sie grüßen. - Jean Paul
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!